Evolent Health, Inc. Accounts Receivable
Evolent Health, Inc. (EVH) had Accounts Receivable of $449.12 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $449.12M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $314.16M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $309.86M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $386.56M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $449.12M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $314.16M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $309.86M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $386.56M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $358.76M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $430.50M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $414.68M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $407.90M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $373.73M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $427.74M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $446.75M 10-K · filed 2025-02-21 | |
| 2023-09-30 | $394.23M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $345.28M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $262.76M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $254.68M 10-K · filed 2024-02-23 | |
| 2022-09-30 | $187.63M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $118.53M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $179.27M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $130.60M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $175.23M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $242.50M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $185.10M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $124.06M 10-K · filed 2022-02-24 | $125.99M 10-K · filed 2021-02-26 |
| 2020-09-30 | $95.32M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $95.84M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $107.51M 10-Q · filed 2020-05-28 | |
| 2019-12-31 | $75.67M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $74.87M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $71.38M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $65.63M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $80.21M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $60.05M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $70.85M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $66.14M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $48.95M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $43.97M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $45.80M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $44.64M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $40.63M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $21.99M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $30.34M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $25.22M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $20.38M 10-K · filed 2017-03-03 | |
| 2015-09-30 | $30.54M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $24.04M 10-Q · filed 2015-08-07 | |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |